Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher Rushton, Ryan D. Morin, Laura K. Hilton et al.|Blood Advances|2020Cited by 120
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activityXiaojie Yu, Mark S. Cragg|Communications Biology|2021Cited by 53
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanismsAlexander P. Simpson, Mark S. Cragg|Cell Reports|2022Cited by 23
Prognostic significance of <i>FCGR2B</i> expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMałgorzata Nowicka, Mark S. Cragg, Laura K. Hilton et al.|Blood Advances|2021Cited by 18